Skip to main content
XOMA logo

XOMA Royalty Corporation

XOMANASDAQHealthcareBiotechnology

$40.17Today:- (-)1Y +17.22%

As of Jul 21, 2026 close

Market cap
$712.28M
P/E (TTM)
21.04
Forward P/E
-
Dividend yield
-
52-week range
$22.29$45.22
Volume (live)
-
Avg. volume (3M)
-

XOMA was delisted on Oct 24, 2026. Data shown is historical and no longer updated.

XOMA Royalty (XOMA) Income Statement

XOMA Royalty reported revenue of $11.66M in fiscal 2025 (fiscal year ended Dec 31, 2025), up 14.1% from $10.22M a year earlier. Net income was $31.71M, a net margin of 272.0%. Gross margin was 447.2% and operating margin 97.6%. In the most recent quarter, Q2 fiscal 2026 (ended Jun 30, 2026), revenue was $17.00M, up 29.5% from the same quarter a year earlier.

XOMA Royalty Income Statement Analysis

Values in millions USD

Scroll to see more
XOMA Royalty Corporation income statement - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Revenue & Gross Profit
Revenue11.6610.224.766.0338.1629.3918.375.3052.69
Cost of Revenue1.712.880.140.150.170.171.251.687.88
Gross Profit52.1528.494.626.0337.9929.2217.123.6244.82
Operating Expenses
Research & Development1.712.880.140.150.170.171.251.687.88
Selling, General & Administrative36.0934.4827.1823.1920.4616.8021.0018.5624.34
Operating Expenses0.2850.2046.4623.4420.4616.8021.0020.2532.21
Operating Income11.38-39.98-41.85-17.4117.5312.42-3.89-16.8617.03
Other Income/Expense
Interest Income0.006.490.000.690.000.160.000.000.00
Interest Expense13.0313.840.570.000.46-1.841.920.921.24
Other Income/Expense33.4634.341.020.30-1.640.051.903.42-0.77
Income
Income Before Tax31.82-19.48-40.83-17.1215.8911.80-1.98-13.4416.26
Income Tax Expense0.10-5.660.00-0.020.09-1.500.00-0.101.66
Net Income31.71-13.82-40.83-17.1215.8013.30-1.98-13.3414.60
Net Income - Continuous Operations31.71-13.82-40.83-17.1015.8013.30-1.98-13.3414.60
Net Income - Discontinued Operations---------
EBITDA47.82-5.42-22.56-17.3116.5212.44-3.86-12.4920.78
EBIT44.85-5.64-40.26-17.4116.3512.42---
Depreciation & Amortization2.960.210.900.100.170.020.030.030.30
Earnings Per Share
Basic EPS2.00-2.00-4.00-2.001.001.00-1.00-2.001.00
Diluted EPS1.00-2.00-4.00-2.001.001.00-1.00-2.001.00
Basic Shares Outstanding12.0811.7011.4711.4111.2910.678.768.377.62
Diluted Shares Outstanding17.9811.7011.4711.4112.1911.508.768.377.98

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About XOMA Royalty Financial Statements

What was XOMA Royalty's revenue in fiscal 2025?

XOMA Royalty reported revenue of $11.66M in fiscal 2025 (fiscal year ended Dec 31, 2025). That was up 14.1% from $10.22M a year earlier.

Is XOMA Royalty profitable?

Yes. XOMA Royalty earned net income of $31.71M in fiscal 2025, a net margin of 272.0%. In fiscal 2024 it lost $13.82M.

What is XOMA Royalty's operating margin?

XOMA Royalty's operating income was $11.38M on revenue of $11.66M in fiscal 2025, an operating margin of 97.6%, compared with -391.2% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition